Apollo Medical (NASDAQ:AMEH) Coverage Initiated at William Blair

Equities researchers at William Blair assumed coverage on shares of Apollo Medical (NASDAQ:AMEHGet Rating) in a report issued on Wednesday, MarketBeat Ratings reports. The firm set an “outperform” rating on the stock.

Separately, Barclays lifted their price objective on shares of Apollo Medical from $50.00 to $57.00 and gave the stock an “equal weight” rating in a research report on Monday, August 8th.

Apollo Medical Stock Down 2.7 %

AMEH opened at $40.58 on Wednesday. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.49 and a quick ratio of 2.49. The company’s 50-day moving average is $46.80 and its 200 day moving average is $42.49. Apollo Medical has a fifty-two week low of $29.52 and a fifty-two week high of $133.23. The firm has a market capitalization of $2.29 billion, a P/E ratio of 25.36 and a beta of 0.75.

Hedge Funds Weigh In On Apollo Medical

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Mutual of America Capital Management LLC raised its holdings in Apollo Medical by 5.5% during the 1st quarter. Mutual of America Capital Management LLC now owns 5,442 shares of the company’s stock valued at $264,000 after buying an additional 282 shares during the last quarter. FMR LLC raised its holdings in Apollo Medical by 36.1% in the 2nd quarter. FMR LLC now owns 1,067 shares of the company’s stock worth $41,000 after purchasing an additional 283 shares in the last quarter. Maryland State Retirement & Pension System grew its position in shares of Apollo Medical by 2.0% in the 2nd quarter. Maryland State Retirement & Pension System now owns 15,449 shares of the company’s stock worth $596,000 after buying an additional 302 shares during the period. Zebra Capital Management LLC grew its position in shares of Apollo Medical by 8.1% in the 2nd quarter. Zebra Capital Management LLC now owns 6,194 shares of the company’s stock worth $239,000 after buying an additional 463 shares during the period. Finally, Handelsbanken Fonder AB grew its position in shares of Apollo Medical by 7.5% in the 2nd quarter. Handelsbanken Fonder AB now owns 7,200 shares of the company’s stock worth $278,000 after buying an additional 500 shares during the period. Hedge funds and other institutional investors own 32.03% of the company’s stock.

About Apollo Medical

(Get Rating)

Apollo Medical Holdings, Inc, a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

Further Reading

Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.